News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Jamie M. Terrell, PharmD

Articles by Jamie M. Terrell, PharmD

Incretin Mimetics: Pros and Cons, and Emerging Agents in Diabetes Treatment

ByJamie M. Terrell, PharmD,Tibb F. Jacobs, PharmD, BCPS

December 14th 2013

Drug Pipeline

Latest Updated Articles

Incretin Mimetics: Pros and Cons, and Emerging Agents in Diabetes Treatment
Published: December 14th 2013 | Updated:

Trending on AJMC

CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL

Barriers to Treatment in Pediatric Myasthenia Gravis: Jonathan Strober, MD

Emerging Breakthroughs in Neurodegenerative Disease Treatments: Kavita Nair, PhD, FAAN

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.